It works through the central nervous system, which makes it a genuinely different tool from Ozempic or Wegovy something worth understanding if youre comparing your options
Fu Z, Mui D, Zhu H, Zhang Y
No, Retatrutide is still investigational and not approved by regulatory authorities
The SELECT cardiovascular outcomes trial (NEJM, 2023) showed a 20% reduction in major adverse cardiovascular events among patients with existing heart disease -- data that no other GLP-1 in this class has yet matched
Algunos estudios sugieren que el uso crnico de secretagogos de la GH, como la ipamorelina, podra aumentar el riesgo de ciertas enfermedades, reducir la esperanza de vida o acelerar el envejecimiento celular, aunque estas observaciones son preliminares